Search for other papers by Margarida Brito in
Google Scholar
PubMed
Search for other papers by Susana Prazeres in
Google Scholar
PubMed
Search for other papers by Marta Malheiros in
Google Scholar
PubMed
a drug, it competes with estradiol with high affinity to the estrogen receptor (ER); the complex fulvestrant–ER causes an unstable conformational change with ER degradation and inhibition of estrogen signalling ( 2 ). Fulvestrant was mainly studied
Search for other papers by Orwa Dandash in
Google Scholar
PubMed
Search for other papers by James Allebone in
Google Scholar
PubMed
Search for other papers by Adam Mirabelli in
Google Scholar
PubMed
Search for other papers by Nicholas Russell in
Google Scholar
PubMed
Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
Department of Florey Institute, University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Andrea Gogos in
Google Scholar
PubMed
Search for other papers by Richard A Kanaan in
Google Scholar
PubMed
. Testosterone, and its derivatives, dihydrotestosterone (DHT) and estradiol (E2), have diverse functions in mammalian physiology ( 2 ). Androgen receptors and estradiol receptors are distributed in cortical and subcortical brain regions responsible for cognitive
Search for other papers by Lauren R Cirrincione in
Google Scholar
PubMed
Search for other papers by Bridgit O Crews in
Google Scholar
PubMed
Search for other papers by Jane A Dickerson in
Google Scholar
PubMed
Search for other papers by Matthew D Krasowski in
Google Scholar
PubMed
Search for other papers by Jessica Rongitsch in
Google Scholar
PubMed
Search for other papers by Katherine L Imborek in
Google Scholar
PubMed
CUNY Graduate School of Public Health and Health Policy, New York, New York, USA
Search for other papers by Zil Goldstein in
Google Scholar
PubMed
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
Search for other papers by Dina N Greene in
Google Scholar
PubMed
Introduction Estradiol (17β-estradiol) is a natural sex steroid available in several exogenous preparations. The Endocrine Society recommended high-dose exogenous estradiol treatment as one part of feminizing hormone therapy for transgender
Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands
Search for other papers by M P Schuijt in
Google Scholar
PubMed
Search for other papers by C G J Sweep in
Google Scholar
PubMed
Search for other papers by R van der Steen in
Google Scholar
PubMed
Search for other papers by A J Olthaar in
Google Scholar
PubMed
Search for other papers by N M M L Stikkelbroeck in
Google Scholar
PubMed
Search for other papers by H A Ross in
Google Scholar
PubMed
Search for other papers by A E van Herwaarden in
Google Scholar
PubMed
to determine free testosterone levels. The possible use of free testosterone calculation during pregnancy, when estradiol concentration is substantially increased, is debated as SHBG is also able to bind estradiol with similar binding affinity (3
Search for other papers by Arpna Sharma in
Google Scholar
PubMed
Search for other papers by Vijay Simha Baddela in
Google Scholar
PubMed
Search for other papers by Frank Becker in
Google Scholar
PubMed
Search for other papers by Dirk Dannenberger in
Google Scholar
PubMed
Search for other papers by Torsten Viergutz in
Google Scholar
PubMed
Search for other papers by Jens Vanselow in
Google Scholar
PubMed
fluid and plasma estradiol ( 6 ). Elevated NEFA levels have detrimental effects on bovine GC ( 7 ). In human GC, saturated fatty acids (PA and SA) are known to induce apoptosis, causing potential reproductive abnormalities such as amenorrhea, which is
Search for other papers by Corina Verónica Sasso in
Google Scholar
PubMed
Universidad de Mendoza, Mendoza, Argentina
Search for other papers by Flavia Eliana Santiano in
Google Scholar
PubMed
Universidad de Mendoza, Mendoza, Argentina
Search for other papers by Fiorella Campo Verde Arboccó in
Google Scholar
PubMed
Search for other papers by Leila Ester Zyla in
Google Scholar
PubMed
Search for other papers by Silvana Noemí Semino in
Google Scholar
PubMed
Search for other papers by Martin Eduardo Guerrero-Gimenez in
Google Scholar
PubMed
Search for other papers by Virginia Pistone Creydt in
Google Scholar
PubMed
Search for other papers by Constanza Matilde López Fontana in
Google Scholar
PubMed
Search for other papers by Rubén Walter Carón in
Google Scholar
PubMed
reported to express mostly ERB after stimulation with estradiol (10–1000 nmol/L), with an induction of apoptosis dependent on the dose ( 6 ). With respect to estrogen receptor alpha (ERA), it has been reported that its expression is minimal in normal colon
Search for other papers by Carina Ankarberg-Lindgren in
Google Scholar
PubMed
Search for other papers by Aneta Gawlik in
Google Scholar
PubMed
Search for other papers by Berit Kriström in
Google Scholar
PubMed
Search for other papers by Laura Mazzanti in
Google Scholar
PubMed
Search for other papers by Elisabeth J Ruijgrok in
Google Scholar
PubMed
Diabeter, National Diabetes Care and Research Center, Rotterdam, the Netherlands
Search for other papers by Theo C J Sas in
Google Scholar
PubMed
Introduction Girls with hypogonadism require estrogen replacement therapy to induce puberty and maintain secondary sex characteristics, as well as to attain peak bone mass. These outcomes are achieved by starting with a low estradiol (E 2
Search for other papers by Lian Hollander-Cohen in
Google Scholar
PubMed
Search for other papers by Benjamin Böhm in
Google Scholar
PubMed
Search for other papers by Krist Hausken in
Google Scholar
PubMed
Search for other papers by Berta Levavi-Sivan in
Google Scholar
PubMed
the methylotrophic yeast, Pichia pastoris . Recombinant tFSH and tLH were able to stimulate the release of 11-ketotestosterone (11-KT) from the testes, or the release of estradiol (E2) from the ovaries of tilapia ( 20 , 21 ). Recombinant stFSH and
Search for other papers by Nardin Aslih in
Google Scholar
PubMed
Search for other papers by Mediea Michaeli in
Google Scholar
PubMed
Search for other papers by Diana Mashenko in
Google Scholar
PubMed
Search for other papers by Adrian Ellenbogen in
Google Scholar
PubMed
Search for other papers by Oshrit Lebovitz in
Google Scholar
PubMed
Search for other papers by Yuval Atzmon in
Google Scholar
PubMed
Search for other papers by Einat Shalom-Paz in
Google Scholar
PubMed
success. It is well-established that a very high estradiol (E2) ratio is associated with poor cycle outcomes due to impaired endometrial receptivity ( 2 ). This might cause long-term pregnancy complications due to mal-placentation ( 3 ). However, elevated
Search for other papers by Qi Che in
Google Scholar
PubMed
Search for other papers by Xirong Xiao in
Google Scholar
PubMed
Search for other papers by Jun Xu in
Google Scholar
PubMed
Search for other papers by Miao Liu in
Google Scholar
PubMed
Search for other papers by Yongning Lu in
Google Scholar
PubMed
Search for other papers by Suying Liu in
Google Scholar
PubMed
Search for other papers by Xi Dong in
Google Scholar
PubMed
cancer is often correlated with exceptional estrogen changes and estrogen-induced signaling ( 5 ). We previously verified that 17β-estradiol (E 2 ) upregulated interleukin (IL)-6 expressions in endometrial cancer, which lead to the local E 2 synthesis in